712
T. Hayashi et al. / Journal of Fluorine Chemistry 131 (2010) 709–713
3JHF = 18.0 Hz, 1H), 7.25–7.41 (m, 5H); 13C NMR (100 MHz, CDCl3)
15.61, 20.13, 30.40, 53.08 (d, JCF = 24.0 Hz, C-3), 75.69, 92.22 (d,
2JCF = 19.8 Hz, C-1), 127.54, 128.74, 129.01, 137.75, 166.00 (d,
d
50.8 Hz). MS (EI) m/z 248 [MꢁH2O]+; HRMS (EI) Calcd. for
2
C15H17FO2: 248.1213, Found: 248.1218.
1JCF = 260.2 Hz, C-2); 19F NMR (283 MHz, CDCl3)
d
ꢁ101.00 (ddd,
4.3. Typical procedure for the reaction of dialkylacetals with 1
To solution of phenylacetoaldehyde dimethyl acetal
3JHF = 18.0, 22.2, 50.4 Hz). MS (CI) m/z 191 [MꢁH2O+H]+; HRMS (CI)
Calcd. for C13H16F: 191.1236, Found: 191.1234.
a
(0.17 mmol) in dry dichloromethane (0.25 mL) at ꢁ78 8C under
an argon atmosphere was added TiCl4 (1.0 M solution in dichlor-
omethane; 0.17 mL, 0.17 mmol) dropwise with a syringe. After
stirring at this temperature for 5 min, to the mixture was added
dropwise a solution of 1 (0.035 g, 0.17 mmol) in dichloromethane
(0.28 mL). The reaction mixture was stirred for 1.5 h at ꢁ78 8C. The
resulting mixture was quenched withwater(5 mL), andthe aqueous
layer was extracted with ether (3ꢂ). The combined organic layers
were washed with sat aq NaHCO3, brine, dried over anhydrous
Na2SO4, and concentrated at reduced pressure. The residue was
purified by preparative thin-layer chromatography to afford 3a in
61% yield as a 83:17 mixture of diastereomers.
4.2.8. 5-Benzyloxy-2-fluoro-3-phenyl-pent-1-en-4-ol (2h)
3
1H NMR (300 MHz, CDCl3)
d
2.60 (d, JHH = 4.5 Hz, 1H), 3.22
3
2
3
(dd, JHH = 5.5 Hz, JHH = 9.7 Hz, 1H), 3.38 (dd, JHH = 2.8 Hz,
3
3
2JHH = 9.7 Hz, 1H), 3.62 (dd, JHH = 9.5 Hz, JHF = 24.2 Hz, 1H),
3
4.22 (ddd, JHH = 2.8, 5.5, 9.5 Hz, 1H), 4.39 (d,
2JHH = 11.7 Hz, 1H), 4.47 (dd, B of AB, JHH = 11.7 Hz, 1H), 4.54
A of AB,
2
2
3
2
(dd, JHH = 2.9 Hz, JHF = 50.0 Hz, 1H), 4.70 (dd, JHH = 2.9 Hz,
3JHF = 17.8 Hz, 1H), 7.24–7.35 (m, 10H); 13C NMR (100 MHz,
CDCl3)
d
52.45 (d, 2JCF = 24.7 Hz, C-3), 70.74 (d, 3JCF = 3.3 Hz, C-4),
2
71.47, 73.38, 92.38 (d, JCF = 19.8 Hz, C-1), 127.48, 127.74,
127.80, 128.13 (d, JCF = 1.6 Hz), 128.40, 128.74, 137.66,
137.97, 165.14 (d, JCF = 260.2 Hz, C-2); 19F NMR (283 MHz,
3
1
3
CDCl3)
d
ꢁ101.91 (ddd, JHF = 17.8, 24.2, 50.0 Hz). MS (EI) m/z
4.3.1. 2-Fluoro-4-methoxy-3,5-diphenylpent-1-ene (3a)
3
286 [M]+; HRMS (EI) Calcd. for C18H19FO2: 286.1369, Found:
286.1364.
Major: 1H NMR (300 MHz, CDCl3)
d
2.77 (dd, JHH = 7.1 Hz,
2JHH = 14.0 Hz, 1H), 2.84 (dd, 3JHH = 5.3 Hz, 2JHH = 14.0 Hz, 1H), 3.09
(s, 3H), 3.47 (dd, JHH = 6.6 Hz, JHF = 18.4 Hz, 1H), 3.90–3.96 (m,
1H), 4.31 (dd, JHH = 2.9 Hz, JHF = 50.6 Hz, 1H), 4.66 (dd,
2JHH = 2.9 Hz, JHF = 18.4 Hz, 1H), 7.18–7.39 (m, 10H); 13C NMR
38.85, 53.11 (d, JCF = 24.7 Hz, C-3), 59.01,
82.73, 92.63 (d, 2JCF = 19.8 Hz, C-1), 126.23, 127.17, 128.27, 128.29,
129.43, 129.49, 137.84 (d, JCF = 1.6 Hz), 138.68, 166.48 (d,
3
3
2
3
4.2.9. 2-Fluoro-5-methyl-3-phenyl-oct-1-en-4-ol (2i)
3
3
Major: 1H NMR (300 MHz, CDCl3)
d
0.91 (t, JHH = 6.8 Hz, 3H),
2
0.96 (d, 3JHH = 6.8 Hz, 3H), 1.21–1.55 (m, 5H), 1.81 (br s, 1H), 3.55
(100 MHz, CDCl3)
d
3
3
3
(dd, JHH = 9.3 Hz, JHF = 25.9 Hz, 1H), 4.08 (dt, JHH = 9.3, 2.9 Hz,
2
3
3
1H), 4.42 (dd, JHH = 2.9 Hz, JHF = 50.0 Hz, 1H), 4.61 (dd,
2JHH = 2.9 Hz, JHF = 18.0 Hz, 1H), 7.28–7.36 (m, 5H); 13C NMR
1JCF = 259.4 Hz, C-2); 19F NMR (283 MHz, CDCl3)
d
ꢁ100.11 (dt,
3
(100 MHz, CDCl3)
d 12.44, 14.20, 34.74, 36.66, 53.47 (d,
3JHF = 18.4, 50.6 Hz). MS (EI) m/z 270 [M]+; HRMS (EI) Calcd. for
2
2JCF = 23.1 Hz, C-3), 73.80 (C-4), 92.05 (d, JCF = 19.8 Hz, C-1),
C
18H19FO: 270.1420, Found: 270.1412.
127.57, 128.72, 128.84, 138.30, 165.69 (d, 1JCF = 260.2 Hz, C-2); 19
NMR (283 MHz, CDCl3)
MS (CI) m/z 237 [M+H]+; HRMS (CI) Calcd. for C15H22FO: 237.1654,
F
Minor (selected data): 1H NMR (300 MHz, CDCl3)
d 2.53 (dd,
d
ꢁ101.99 (ddd, 3JHF = 18.0, 25.9, 50.0 Hz).
3JHH = 7.5 Hz, 2JHH = 14.0 Hz, 1H), 2.78 (dd, 3JHH = 3.7 Hz,
2JHH = 14.0 Hz, 1H), 3.27 (s, 3H), 3.44 (dd, JHH = 8.6 Hz,
3
2
Found: 237.1660.
3JHF = 26.0 Hz, 1H), 3.85–3.92 (m, 1H), 4.47 (dd, JHH = 2.9 Hz,
Minor (selected data): 1H NMR (300 MHz, CDCl3)
d
3.98 (m, 1H),
3JHF = 50.2 Hz, 1H), 4.63 (dd, JHH = 2.9 Hz, JHF = 17.6 Hz, 1H),
2
3
2
3
2
4.40 (dd, JHH = 3.1 Hz, JHF = 50.6 Hz, 1H), 4.64 (dd, JHH = 3.1 Hz,
3JHF = 18.1 Hz, 1H); 13C NMR (100 MHz, CDCl3)
14.37, 16.84,
7.09–7.36 (m, 10H); 13C NMR (100 MHz, CDCl3)
d
38.30, 53.93 (d,
4
d
2JCF = 24.7 Hz, C-3), 58.94, 82.75 (d, JCF = 1.6 Hz, C-5), 92.09 (d,
20.27, 32.25, 35.24, 52.69 (d, 2JCF = 23.1 Hz, C-3), 75.75 (C-4), 92.35
2JCF = 20.6 Hz, C-1), 126.19, 127.37, 128.18, 128.46 (d,
(d, 2JCF = 19.8 Hz, C-1); 19F NMR (283 MHz, CDCl3)
3JHF = 18.1, 20.6, 50.6 Hz).
d
ꢁ100.66 (ddd,
3JCF = 1.6 Hz), 128.71, 129.55, 138.54; 19F NMR (283 MHz, CDCl3)
3
d
ꢁ102.21 (ddd, JHF = 17.6, 26.0, 50.2 Hz).
4.2.10. 3,5-Diphenyl-2-fluoro-hex-1-en-4-ol (2j)
4.3.2. 5-Bromo-4-ethoxy-2-fluoro-3-phenylpent-1-ene (3b)
1H NMR (300 MHz, CDCl3)
d
1.35 (d, 3JHH = 6.6 Hz, 3H), 1.52 (br
Major: 1H NMR (300 MHz, CDCl3)
d
1.07(t, 3JHH = 7.1 Hz, 3H), 3.34
3
3
3
2
3
s, 1H), 2.92 (quint, JHH = 6.6 Hz, 1H), 3.49 (dd, JHH = 6.6 Hz,
(dq, JHH = 7.1 Hz, JHH = 9.1 Hz, 1H), 3.35 (dd, JHH = 5.7 Hz,
2JHH = 11.0 Hz, 1H), 3.45 (dd, 3JHH = 5.1 Hz, 2JHH = 11.0 Hz, 1H), 3.63
3
3JHF = 19.8 Hz, 1H), 4.30 (t, JHH = 6.6 Hz, 1H), 4.42 (dd,
2JHH = 3.0 Hz, 3JHF = 50.6 Hz, 1H), 4.69 (dd, 2JHH = 3.0 Hz,
(dq, JHH = 7.1 Hz, JHH = 9.1 Hz, 1H), 3.82 (dd, JHH = 6.4 Hz,
3
2
3
3JHF = 19.8 Hz, 1H), 7.18–7.35 (m, 5H); 13C NMR (75.4 MHz, CDCl3)
3JHF = 18.4 Hz, 1H), 3.98–4.04 (m, 1H), 4.39 (dd, JHH = 3.1 Hz,
2
2
2
3
d
15.25, 42.50, 36.66, 52.50 (d, JCF = 24.0 Hz, C-3), 75.35 (d,
3JHF = 50.4 Hz, 1H), 4.69 (dd, JHH = 3.1 Hz, JHF = 18.4 Hz, 1H),
3JCF = 1.5 Hz, C-4), 92.47 (d, JCF = 19.8 Hz, C-1), 126.56, 127.53,
7.25–7.41 (m, 5H); 13C NMR (100 MHz, CDCl3)
51.75 (d, 2JCF = 24.7 Hz, C-3), 67.04, 78.65 (d, 3JCF = 1.6 Hz, C-4), 93.09
d 15.24, 33.37,
2
1
128.54, 128.57, 129.32, 137.20, 144.67, 166.19 (d, JCF = 260.4 Hz,
C-2); 19F NMR (282 MHz, CDCl3)
d
ꢁ100.70 (dt, JHF = 19.8,
(d, JCF = 19.0 Hz, C-1), 127.45, 128.32, 129.48 (d, JCF = 1.6 Hz),
3
2
4
50.6 Hz). MS (CI) m/z 253 [MꢁH2O+H]+; HRMS (CI) Calcd. for
136.51 (d, JCF = 1.6 Hz), 165.39 (d, JCF = 260.2 Hz, C-2); 19F NMR
3
1
C
18H18F: 253.1393, Found: 253.1396.
(283 MHz, CDCl3)
d
ꢁ100.89(dt, 3JHF = 18.4, 50.4 Hz). MS(EI)m/z286
[M]+;HRMS(EI)Calcd.forC13H1679BrFO:286.0369,Found:286.0370.
4.2.11. 4-Fluoro-2-hydroxy-3-phenyl-pent-4-enoic acid butyl ester
Minor (selected data): 1H NMR (300 MHz, CDCl3)
3JHH = 7.0 Hz, 3H), 3.03 (dd, 3JHH = 4.2 Hz, 2JHH = 11.1 Hz, 1H), 3.44
d 1.18 (t,
(2k)
1H NMR (300 MHz, CDCl3)
d
0.90 (t, 3JHH = 7.3 Hz, 3H), 1.24–1.36
(dd, JHH = 3.5 Hz, JHH = 11.1 Hz, 1H), 3.49 (dq, JHH = 7.0 Hz,
2JHH = 9.0 Hz, 1H), 3.66 (dd, JHH = 9.3 Hz, JHF = 25.7 Hz, 1H),
3
2
3
3
3
3
(m, 2H), 1.49–1.59 (m, 2H), 3.02 (d, JHH = 6.2 Hz, 1H), 3.96 (dd,
3JHH = 4.8 Hz, JHF = 14.0 Hz, 1H), 4.13 (t, JHH = 6.6 Hz, 2H), 4.39
3
3
3
2
3
3.68 (dq, JHH = 7.0 Hz, JHH = 9.0 Hz, 1H), 3.84 (dt, JHH = 3.8 Hz,
2
3
2
2
3
(dd, JHH = 3.1 Hz, JHF = 50.8 Hz, 1H), 4.77 (dd, JHH = 3.1 Hz,
3JHF = 18.5 Hz, 1H), 7.29–7.43 (m, 5H); 13C NMR (100 MHz, CDCl3)
3JHH = 9.3 Hz, 1H), 4.46 (dd, JHH = 2.9 Hz, JHF = 50.0 Hz, 1H), 4.58
(dd, 2JHH = 2.9 Hz, 3JHF = 17.2 Hz, 1H), 7.21–7.27 (m, 5H); 13C NMR
2
d
13.56, 18.93, 30.35, 52.46 (d, 2JCF = 25.6 Hz, C-3), 65.93, 71.96 (d,
(100 MHz, CDCl3)
d
15.27, 34.35, 52.81 (d, JCF = 24.0 Hz, C-3),
3JCF = 2.5 Hz, C-2), 93.97 (d, JCF = 18.1 Hz, C-5), 127.73, 128.61,
66.41, 78.09, 92.57 (d, 2JCF = 19.8 Hz, C-1), 127.71, 128.27, 128.89,
2
3
1
1
128.76, 136.87 (d, JCF = 2.5 Hz), 164.12 (d, JCF = 260.2 Hz, C-4),
173.33; 19F NMR (283 MHz, CDCl3)
164.58 (d, JCF = 261.0 Hz, C-2); 19F NMR (283 MHz, CDCl3)
d
3
d
ꢁ97.33 (ddd, 3JHF = 14.0, 18.5,
ꢁ102.95 (ddd, JHF = 17.2, 25.7, 50.0 Hz).